Cell Stem Cell
Volume 26, Issue 6, 4 June 2020, Pages 832-844.e6
Clinical and Translational ReportThe Rational Development of CD133-Targeting Immunotherapies for Glioblastoma
Under an Elsevier user license
open archive
Graphical Abstract
Keywords
CD133
immunotherapy
glioblastoma
chimeric antigen receptor T cells
dual-antigen T cell engagers
IgG
humanized mice
GBM
Cited by (0)
© 2020 Elsevier Inc.